Seattle Children's Coler Lab: bacteriophage therapies for lung diseases, with partnering opportunities

Rhea Coler's lab at Seattle Children's develops bacteriophage therapies for tuberculosis, nontuberculous mycobacterial infections and cystic fibrosis lung disease, working with Graham Hatfull's lab at the University of Pittsburgh with Gates Foundation support. It runs Pacific Northwest "phage hunts" to widen the therapeutic phage collection and is at preclinical in vitro and in vivo stages; the page lists sponsored research, collaboration, consultation, licensing, screening and contract-service partnering.